These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

660 related articles for article (PubMed ID: 34544279)

  • 1. SARS-CoV-2 Nsp5 Demonstrates Two Distinct Mechanisms Targeting RIG-I and MAVS To Evade the Innate Immune Response.
    Liu Y; Qin C; Rao Y; Ngo C; Feng JJ; Zhao J; Zhang S; Wang TY; Carriere J; Savas AC; Zarinfar M; Rice S; Yang H; Yuan W; Camarero JA; Yu J; Chen XS; Zhang C; Feng P
    mBio; 2021 Oct; 12(5):e0233521. PubMed ID: 34544279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 NSP5 and N protein counteract the RIG-I signaling pathway by suppressing the formation of stress granules.
    Zheng Y; Deng J; Han L; Zhuang MW; Xu Y; Zhang J; Nan ML; Xiao Y; Zhan P; Liu X; Gao C; Wang PH
    Signal Transduct Target Ther; 2022 Jan; 7(1):22. PubMed ID: 35075101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG-I/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING signaling pathways.
    Han L; Zhuang MW; Deng J; Zheng Y; Zhang J; Nan ML; Zhang XJ; Gao C; Wang PH
    J Med Virol; 2021 Sep; 93(9):5376-5389. PubMed ID: 33913550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the RLR signaling pathway by SARS-CoV-2 ORF7b is mediated by MAVS and abrogated by ORF7b-homologous interfering peptide.
    Xiao X; Fu Y; You W; Huang C; Zeng F; Gu X; Sun X; Li J; Zhang Q; Du W; Cheng G; Liu Z; Liu L
    J Virol; 2024 May; 98(5):e0157323. PubMed ID: 38572974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 nsp5 Exhibits Stronger Catalytic Activity and Interferon Antagonism than Its SARS-CoV Ortholog.
    Chen J; Li Z; Guo J; Xu S; Zhou J; Chen Q; Tong X; Wang D; Peng G; Fang L; Xiao S
    J Virol; 2022 Apr; 96(8):e0003722. PubMed ID: 35389264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential roles of RIG-I like receptors in SARS-CoV-2 infection.
    Yang DM; Geng TT; Harrison AG; Wang PH
    Mil Med Res; 2021 Sep; 8(1):49. PubMed ID: 34488908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 proteases PLpro and 3CLpro cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1): implications for disease presentation across species.
    Moustaqil M; Ollivier E; Chiu HP; Van Tol S; Rudolffi-Soto P; Stevens C; Bhumkar A; Hunter DJB; Freiberg AN; Jacques D; Lee B; Sierecki E; Gambin Y
    Emerg Microbes Infect; 2021 Dec; 10(1):178-195. PubMed ID: 33372854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 Nsp5 Activates NF-κB Pathway by Upregulating SUMOylation of MAVS.
    Li W; Qiao J; You Q; Zong S; Peng Q; Liu Y; Hu S; Liu W; Li S; Shu X; Sun B
    Front Immunol; 2021; 12():750969. PubMed ID: 34858407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) membrane (M) protein inhibits type I and III interferon production by targeting RIG-I/MDA-5 signaling.
    Zheng Y; Zhuang MW; Han L; Zhang J; Nan ML; Zhan P; Kang D; Liu X; Gao C; Wang PH
    Signal Transduct Target Ther; 2020 Dec; 5(1):299. PubMed ID: 33372174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 ORF9b inhibits RIG-I-MAVS antiviral signaling by interrupting K63-linked ubiquitination of NEMO.
    Wu J; Shi Y; Pan X; Wu S; Hou R; Zhang Y; Zhong T; Tang H; Du W; Wang L; Wo J; Mu J; Qiu Y; Yang K; Zhang LK; Ye BC; Qi N
    Cell Rep; 2021 Feb; 34(7):108761. PubMed ID: 33567255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C Virus Infection Is Inhibited by a Noncanonical Antiviral Signaling Pathway Targeted by NS3-NS4A.
    Vazquez C; Tan CY; Horner SM
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31534039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MERS-CoV-nsp5 expression in human epithelial BEAS 2b cells attenuates type I interferon production by inhibiting IRF3 nuclear translocation.
    Zhang Y; Kandwal S; Fayne D; Stevenson NJ
    Cell Mol Life Sci; 2024 Oct; 81(1):433. PubMed ID: 39395053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Papain-like protease of SARS-CoV-2 inhibits RLR signaling in a deubiquitination-dependent and deubiquitination-independent manner.
    Ran XH; Zhu JW; Chen YY; Ni RZ; Mu D
    Front Immunol; 2022; 13():947272. PubMed ID: 36032116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 ORF10 suppresses the antiviral innate immune response by degrading MAVS through mitophagy.
    Li X; Hou P; Ma W; Wang X; Wang H; Yu Z; Chang H; Wang T; Jin S; Wang X; Wang W; Zhao Y; Zhao Y; Xu C; Ma X; Gao Y; He H
    Cell Mol Immunol; 2022 Jan; 19(1):67-78. PubMed ID: 34845370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammalian orthoreovirus capsid protein σ3 antagonizes RLR-mediated antiviral responses by degrading MAVS.
    Li D; Mo R; Li X; Cheng R; Xie J; Li H; Yang Y; Li S; Li H; Yan Z; Wei S; Idris A; Li X; Feng R
    mSphere; 2024 Jun; 9(6):e0023624. PubMed ID: 38757961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual targeting of RIG-I and MAVS by MARCH5 mitochondria ubiquitin ligase in innate immunity.
    Park YJ; Oanh NTK; Heo J; Kim SG; Lee HS; Lee H; Lee JH; Kang HC; Lim W; Yoo YS; Cho H
    Cell Signal; 2020 Mar; 67():109520. PubMed ID: 31881323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 nsp12 attenuates type I interferon production by inhibiting IRF3 nuclear translocation.
    Wang W; Zhou Z; Xiao X; Tian Z; Dong X; Wang C; Li L; Ren L; Lei X; Xiang Z; Wang J
    Cell Mol Immunol; 2021 Apr; 18(4):945-953. PubMed ID: 33637958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 Nucleocapsid Protein Targets RIG-I-Like Receptor Pathways to Inhibit the Induction of Interferon Response.
    Oh SJ; Shin OS
    Cells; 2021 Mar; 10(3):. PubMed ID: 33801464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RIG-I-Like Receptor-Mediated Recognition of Viral Genomic RNA of Severe Acute Respiratory Syndrome Coronavirus-2 and Viral Escape From the Host Innate Immune Responses.
    Kouwaki T; Nishimura T; Wang G; Oshiumi H
    Front Immunol; 2021; 12():700926. PubMed ID: 34249006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 main protease suppresses type I interferon production by preventing nuclear translocation of phosphorylated IRF3.
    Fung SY; Siu KL; Lin H; Yeung ML; Jin DY
    Int J Biol Sci; 2021; 17(6):1547-1554. PubMed ID: 33907518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.